Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1966 1
1967 4
1970 3
1971 1
1972 2
1974 1
1975 4
1979 1
1982 4
1984 4
1985 5
1986 5
1987 2
1988 3
1989 14
1990 13
1991 6
1992 2
1993 3
1994 5
1995 4
1996 7
1997 8
1998 9
1999 7
2000 7
2001 7
2002 14
2003 9
2004 16
2005 23
2006 21
2007 22
2008 23
2009 25
2010 25
2011 17
2012 5
2013 2
2014 3
2015 7
2016 4
2017 5
2018 2
2019 4
2020 2
2021 6
2022 8
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

345 results

Results by year

Filters applied: . Clear all
Page 1
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia.
Hochhaus A, Larson RA, Guilhot F, Radich JP, Branford S, Hughes TP, Baccarani M, Deininger MW, Cervantes F, Fujihara S, Ortmann CE, Menssen HD, Kantarjian H, O'Brien SG, Druker BJ; IRIS Investigators. Hochhaus A, et al. N Engl J Med. 2017 Mar 9;376(10):917-927. doi: 10.1056/NEJMoa1609324. N Engl J Med. 2017. PMID: 28273028 Free PMC article. Clinical Trial.
Mucocutaneous paraneoplastic syndromes in hematologic malignancies.
Zappasodi P, Forno C, Corso A, Lazzarino M. Zappasodi P, et al. Among authors: lazzarino m. Int J Dermatol. 2006 Jan;45(1):14-22. doi: 10.1111/j.1365-4632.2005.02668.x. Int J Dermatol. 2006. PMID: 16426369 Review. No abstract available.
Clinical pharmacokinetics of tretinoin.
Regazzi MB, Iacona I, Gervasutti C, Lazzarino M, Toma S. Regazzi MB, et al. Among authors: lazzarino m. Clin Pharmacokinet. 1997 May;32(5):382-402. doi: 10.2165/00003088-199732050-00004. Clin Pharmacokinet. 1997. PMID: 9160172 Review.
Overview of alemtuzumab therapy for the treatment of T-cell lymphomas.
Zinzani PL, Corradini P, Gallamini A, Grossi A, Lazzarino M, Marchetti M, Martelli M, Rossi G, Vitolo U. Zinzani PL, et al. Among authors: lazzarino m. Leuk Lymphoma. 2012 May;53(5):789-95. doi: 10.3109/10428194.2011.629701. Epub 2011 Nov 18. Leuk Lymphoma. 2012. PMID: 21980956 Review.
Perspectives of Microscopy Methods for Morphology Characterisation of Extracellular Vesicles from Human Biofluids.
Malenica M, Vukomanović M, Kurtjak M, Masciotti V, Dal Zilio S, Greco S, Lazzarino M, Krušić V, Perčić M, Jelovica Badovinac I, Wechtersbach K, Vidović I, Baričević V, Valić S, Lučin P, Kojc N, Grabušić K. Malenica M, et al. Among authors: lazzarino m. Biomedicines. 2021 May 26;9(6):603. doi: 10.3390/biomedicines9060603. Biomedicines. 2021. PMID: 34073297 Free PMC article. Review.
Atomic force spectroscopy-based essay to evaluate oocyte postovulatory aging.
Battistella A, Andolfi L, Zanetti M, Dal Zilio S, Stebel M, Ricci G, Lazzarino M. Battistella A, et al. Among authors: lazzarino m. Bioeng Transl Med. 2022 Jun 9;7(3):e10294. doi: 10.1002/btm2.10294. eCollection 2022 Sep. Bioeng Transl Med. 2022. PMID: 36176606 Free PMC article.
345 results